🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/05/2011 | 6,83 | 6,86 | 6,71 | 6,75 | -1,64% | 2,28% | 149.720 |
| 04/05/2011 | 6,97 | 6,98 | 6,84 | 6,86 | -1,08% | 1,97% | 105.958 |
| 03/05/2011 | 6,95 | 6,99 | 6,92 | 6,94 | -0,27% | 0,90% | 128.240 |
| 02/05/2011 | 6,97 | 7,02 | 6,92 | 6,96 | +0,36% | 1,34% | 157.094 |
| 29/04/2011 | 6,99 | 7,08 | 6,87 | 6,93 | -1,16% | 3,04% | 301.364 |
| 28/04/2011 | 6,60 | 7,09 | 6,57 | 7,01 | +6,24% | 7,85% | 330.218 |
| 27/04/2011 | 6,56 | 6,61 | 6,44 | 6,60 | +0,86% | 2,66% | 84.959 |
| 26/04/2011 | 6,36 | 6,74 | 6,36 | 6,54 | +2,14% | 5,98% | 259.526 |
| 25/04/2011 | 6,33 | 6,42 | 6,33 | 6,41 | +0,88% | 1,38% | 91.852 |
| 21/04/2011 | 6,42 | 6,42 | 6,33 | 6,35 | -0,29% | 1,36% | 112.210 |
| 20/04/2011 | 6,36 | 6,38 | 6,14 | 6,37 | +2,72% | 3,73% | 237.244 |
| 19/04/2011 | 6,24 | 6,26 | 6,17 | 6,20 | -0,30% | 1,40% | 86.081 |
| 18/04/2011 | 6,09 | 6,22 | 6,04 | 6,22 | +0,60% | 2,87% | 126.316 |
| 15/04/2011 | 5,96 | 6,19 | 5,95 | 6,18 | +3,45% | 4,19% | 134.011 |
| 14/04/2011 | 5,96 | 6,05 | 5,91 | 5,98 | -0,52% | 2,41% | 61.235 |
| 13/04/2011 | 5,98 | 6,09 | 5,90 | 6,01 | +0,73% | 3,23% | 133.851 |
| 12/04/2011 | 6,06 | 6,15 | 5,86 | 5,96 | -2,15% | 4,84% | 169.597 |
| 11/04/2011 | 6,16 | 6,22 | 6,09 | 6,09 | -1,21% | 2,03% | 70.532 |
| 08/04/2011 | 6,34 | 6,34 | 6,17 | 6,17 | -1,98% | 2,75% | 72.295 |
| 07/04/2011 | 6,33 | 6,42 | 6,24 | 6,29 | -0,49% | 2,86% | 124.072 |
| 06/04/2011 | 6,23 | 6,35 | 6,19 | 6,33 | +1,70% | 2,50% | 152.285 |
| 05/04/2011 | 6,18 | 6,26 | 6,15 | 6,22 | +0,30% | 1,71% | 243.656 |
| 04/04/2011 | 6,19 | 6,23 | 6,18 | 6,20 | +0,10% | 0,81% | 61.074 |
| 01/04/2011 | 6,24 | 6,24 | 6,18 | 6,19 | -0,70% | 1,00% | 85.761 |
| 31/03/2011 | 6,22 | 6,25 | 6,21 | 6,24 | +0,30% | 0,70% | 173.765 |
| 30/03/2011 | 6,27 | 6,28 | 6,21 | 6,22 | -0,30% | 1,19% | 155.170 |
| 29/03/2011 | 6,24 | 6,30 | 6,16 | 6,24 | +0,20% | 2,30% | 132.408 |
| 28/03/2011 | 6,46 | 6,46 | 6,21 | 6,23 | -3,01% | 3,86% | 148.758 |
| 25/03/2011 | 6,43 | 6,49 | 6,30 | 6,42 | +0,10% | 2,91% | 134.011 |
| 24/03/2011 | 6,35 | 6,43 | 6,29 | 6,41 | +1,38% | 2,06% | 171.200 |